Učitavanje...

Oligoclonal Antibodies to Target the ErbB Family

INTRODUCTION: Use of monoclonal antibodies to inhibit signaling through the ErbB receptor tyrosine kinase family has proven to be an effective strategy for treating ErbB-driven cancers. Advances in the field of antibody engineering and manufacturing now allow us to more effectively mimic the natural...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Expert Opin Biol Ther
Glavni autori: D'Souza, Jimson W., Robinson, Matthew K.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4480362/
https://ncbi.nlm.nih.gov/pubmed/25936923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1042362
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!